** Shares of contract research providers fall after
Jefferies cuts its rating on Charles River Laboratories CRL.N ,
citing fears of falling funding among clients urn:newsml:reuters.com:*:nL3N2WN33U
** The sector has come under pressure after companies warned
in February that declining biotech funding could weigh on demand
for contract research
** Jefferies also cuts rating on Syneos Health SYNH.O to
"hold" from "buy" and lowers PT to $75 from $101
** Says SYNH revenue growth in 2022 will be challenged as
biotechs cut development spending, leading to weak bookings
** Shares of Charles River and Syneos down 4-8%
(Reporting by Manas Mishra)
((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15))